Clinical Effects of a Nucleotides-Supplemented Infant Formula
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00292812|
Recruitment Status : Completed
First Posted : February 16, 2006
Last Update Posted : October 23, 2007
|Condition or disease||Intervention/treatment||Phase|
|Nutritional Requirements||Drug: Nutritional supplementation (nucleotides)||Not Applicable|
Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will be monitored prospectively for the following outcome parameters:
- Growth percentiles.
- Behaviour and infantile colic.
- Bowel habits.
- Side effects.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides|
|Study Start Date :||March 2006|
|Actual Study Completion Date :||October 2007|
- Growth percentiles, Behaviour and infantile colic, Bowel habits.
- Side effects.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00292812
|Soroka Medical Center|
|Beer-Sheva, Israel, 84101|
|Principal Investigator:||Zvi Weizman, MD||Head, Pediatric GI and Nutrition Unit|